Synthesis of 5-deazaflavin derivatives and their activation of p53 in cells

Wilson, J., Henderson, G., Black, F., Sutherland, A., Ludwig, R., Vousden, K. and Robins, D. (2007) Synthesis of 5-deazaflavin derivatives and their activation of p53 in cells. Bioorganic and Medicinal Chemistry Letters, 15, pp. 77-86. (doi: 10.1016/j.bmc.2006.10.011)

Full text not currently available from Enlighten.

Abstract

A family of 5-deazaflavin derivatives has been synthesised using a two-step convergent strategy. The biological activity of these compounds was evaluated in cells, by assessing their ability to stabilize and activate p53. These compounds may act as low molecular weight inhibitors of the E3 activity of HMD2 in tumours that retain wild-type p53. Importantly, we have demonstrated that the nitro group present in all three of the original lead compounds [1-3 (HL198C-E)] is not essential for observation of this biological activity

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Sutherland, Professor Andrew and Vousden, Karen and Robins, Prof David
Authors: Wilson, J., Henderson, G., Black, F., Sutherland, A., Ludwig, R., Vousden, K., and Robins, D.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Science and Engineering > School of Chemistry
Journal Name:Bioorganic and Medicinal Chemistry Letters
ISSN:0960-894X

University Staff: Request a correction | Enlighten Editors: Update this record